Table 4 Relative risk of incidence and mortality related to solar UV-B exposure, northern versus southern United States boundary, non-Hispanic whites (95% CI in parentheses): Cancer sites with no evidence of an inverse association with solar UV-B exposure (see notes for Table 2).
From: Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002
Incidence | Mortality | |||
|---|---|---|---|---|
Cancer site | Males | Females | Males | Females |
Liver and intrahepatic bile duct | 1.01 (0.95–1.08) | 1.05 (0.96–1.14) | 0.88 (0.85–0.92) | 0.85 (0.81–0.89) |
Nose, nasal cavity, and inner ear | 0.80 (0.68–0.95) | 0.85 (0.71–1.03) | 0.93 (0.76–1.13) | 0.99 (0.80–1.23) |
Larynx | 0.87 (0.82–0.92) | 0.80 (0.72–0.89) | 1.04 (0.98–1.11) | 0.96 (0.86–1.07) |
Bone and joint | 0.83 (0.69–1.01) | 0.95 (0.78–1.17) | 0.62 (0.54–0.72) | 0.57 (0.49–0.66) |
Soft tissue, including heart | 0.84 (0.77–0.92) | 0.94 (0.85–1.03) | 1.10 (1.02–1.19) | 1.23 (1.14–1.33) |
Ovary | 1.03 (0.99–1.06) | 1.09 (1.06–1.11) | ||
Brain and other nervous system | 1.08 (1.02–1.14) | 1.07 (1.01–1.14) | 0.91 (0.87–0.94) | 0.86 (0.83–0.90) |
Thyroid (males) | 1.05 (0.96–1.13) | 1.00 (0.87–1.16) | ||
Miscellaneous sites | 0.83 (0.79–0.86) | 0.93 (0.89–-0.97) | 1.16 (1.13–1.18) | 1.23 (1.20–1.26) |